Inter-laboratory validation of PCR-based HPV detection in pathology specimens

Virchows Archiv

Volumn 451, Issue 3, 2007, Pages 701-716

  Petersen, Iver ^a   Schewe, Christiane ^a   Schlüns, Karsten ^a   Dietel, Manfred ^a   Speich, Norbert ^b   Schmitt, Christoph ^b   Bollmann, Magdolna ^b   Sotlar, Karl ^c   Bültmann, Burkhard ^c   Dours Zimmermann, Maria T ^d   Padberg, Barbara ^d   Zimmermann, Dieter R ^d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Institut für Molekularpathologie und Gendiagnostik GmbH   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Histology; HPV; HPV gallery; Human papilloma virus; Morphology; Multicentre study; PCR; Quality assurance; Reference standards

Indexed keywords

PARAFFIN;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; HUMAN; HUMAN TISSUE; MALE; METHODOLOGY; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VALIDATION STUDY; VIRUS DETECTION; WART VIRUS;

ALPHAPAPILLOMAVIRUS; BIOPSY; CERVIX UTERI; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 11; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 6; HUMANS; LABORATORIES; MALE; PARAFFIN EMBEDDING; POLYMERASE CHAIN REACTION; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS;

EID: 34548307144     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-007-0437-0     Document Type: Article

References (53)

1. Bauer HM, Greer CE, Manos MM (1992) Determination of genital human papillomavirus infection using consensus PCR. In: Herrington CS, McGee JOD (eds) Diagnostic molecular pathology: a practical approach. Oxford University Press, Oxford, UK, pp 132-152
2. Bekkers RL, Massuger LF, Bulten J, Melchers WJ (2004) Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer. Rev Med Virol 14:95-105
3. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244-265
4. Brink AA, Zielinski GD, Steenbergen RD, Snijders PJ, Meijer CJ (2005) Clinical relevance of human papillomavirus testing in cytopathology. Cytopathology 16:7-12
5. Brule van den AJ, Snijders PJ, Raaphorst PM, Schrijnemakers HF, Delius H, Gissmann L, Meijer CJ, Walboomers JM (1992) General primer polymerase chain reaction in combination with sequence analysis for identification of potentially novel human papillomavirus genotypes in cervical lesions. J Clin Microbiol 30:1716-1721
6. Brummer O, Hollwitz B, Bohmer G, Kuhnle H, Petry KU (2006) Human papillomavirus-type persistence patterns predict the clinical outcome of cervical intraepithelial neoplasia. Gynecol Oncol 102:517-522
7. Burd EM (2003) Human papillomavirus and cervical cancer. Clin Microbiol Rev 16:1-17 (Review)
8. Coombs NJ, Gough AC, Primrose JN (1999) Optimisation of DNA and RNA extraction from archival formalin-fixed tissue. Nucleic Acids Res 27:e12
9. Davies P, Arbyn M, Dillner J, Kitchener HC, Meijer CJ, Ronco G, Hakama M (2006) A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening. Int J Cancer 118:791-796
10. Desai MS, Cubie HA (2005) The HPV test in cervical screening: a brave new world? Cytopathology 16:3-6
11. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ (1995) The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76:1057-1062
12. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H (2004) Classification of papillomaviruses. Virology 324:17-27
13. Doorbar J (2006) Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) 110:525-541
14. Fleiss JL (1971) Measuring nominal scale agreement among many raters. Psychol Bull 76:378-382
15. Gravitt PE, Jamshidi R (2005) Diagnosis and management of oncogenic cervical human papillomavirus infection. Infect Dis Clin North Am 19:439-458
16. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM (1998) Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 36:3020-3027
17. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ (2000) Improved amplification of genital human papillomavirus. J Clin Microbiol 38:357-361
18. Greer CE, Petersen SL, Kiviat NB, Manos MM (1991) PCR Amplification from Paraffin-Embedded tissues. Am J Clin Pathol 95:117-124
19. Greer CE, Wheeler CM, Manos MM (1994) Sample preparation and PCR amplification from paraffin-embedded tissues. PCR Methods Appl 3:S113-S122
20. Hidalgo A, Schewe C, Petersen S et al (2000) Human papilloma virus status and chromosomal imbalances in primary cervical carcinomas and tumour cell lines. Eur J Cancer 36:542-554
21. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME et al (1994) Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 169:235-240
22. Höfler H (1999) Leitlinien der Deutschen Gesellschaft für Pathologie. Leitlinien Diagnostische Molekulare Pathologie. Der Pathologe 20:306-307
23. Hopman AH, Theelen W, Hommelberg PP, Kamps MA, Herrington CS, Morrison LE, Speel EJ, Smedts F, Ramaekers FC (2006) Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer. J Pathol 210:412-419
24. Huang HJ, Huang SL, Lin CY, Lin RW, Chao FY, Chen MY, Chang TC, Hsueh S, Hsu KH, Lai CH (2004) Human papillomavirus genotyping by a polymerase chain reaction-based genechip method in cervical carcinoma treated with neoadjuvant chemotherapy plus radical surgery. Int J Gynecol Cancer 14:639-649
25. Hubbard RA (2003) Human papillomavirus testing methods. Arch Pathol Lab Med 127:940-945
26. Jacobs MV, Snijders PJ, Voorhorst FJ, Dillner J, Forslund O, Johansson B, von Knebel Doeberitz M, Meijer CJ, Meyer T, Nindl I, Pfister H, Stockfleth E, Strand A, Wadell G, Walboomers JM (1999) Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison. J Clin Pathol 52:498-503
27. Johnson T, Bryder K, Corbet S, Fomsgaard A (2003) Routine genotyping of human papillomavirus samples in Denmark. APMIS 111:398-404
28. Kleter B, van Doorn LJ, ter Schegget J, Schrauwen L, van Krimpen K, Burger M, ter Harmsel B, Quint W (1998) Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 153:1731-1739
29. Laeng RH, Altermatt HJ, Scheithauer BW, Zimmermann DR (1998) Amyloidomas of the nervous system-a monoclonal B-cell disorder with monotypic amyloid light chain lambda amyloid production. Cancer 82:362-374
30. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 22:159-174
31. Molijn A, Kleter B, Quint W, van Doorn LJ (2005) Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol 32(Suppl 1):S43-S51
32. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ (2003) International agency for research on cancer multicenter cervical cancer study group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527
33. Muñoz N, Bosch FX, Castellsagué X, Díaz M, de Sanjose S, Hammouda D, Shah KV, Meijer CJLM (2004) Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111:278-285
34. Nakagawa S, Yoshikawa H, Jimbo H, Onda T, Yasugi T, Matsumoto K, Kino N, Kawana K, Kozuka T, Nakagawa K, Aoki M, Taketani Y (1999) Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 mutations. Br J Cancer 79:1139-1144
35. Naso MF, Zimmermann DR, Iozzo RV (1994) Characterization of the complete genomic structure of the human versican gene and functional analysis of its promoter. J Biol Chem 269:32999-33008
36. Olert J, Wiedorn KH, Goldmann T, Kuhl H, Mehraein Y, Scherthan H, Niketeghad F, Vollmer E, Muller AM, Muller-Navia J (2001) HOPE fixation: a novel fixing method and paraffin-embedding technique for human soft tissues. Pathol Res Pract 197:823-826
37. Padberg BC, Bode B, Zimmermann DR (2006) Metastatic warty (condylomatous) carcinoma of the uterine cervix associated with low-risk HPV type 6. Acta Cytol 50:235-238
38. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Ehrlich HA (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491
39. Savelkoul PH, Catsburg A, Mulder S, Oostendorp L, Schirm J, Wilke H, van der Zanden AG, Noordhoek GT (2006) Detection of Mycobacterium tuberculosis complex with Real Time PCR: comparison of different primer-probe sets based on the IS6110 element. J Microbiol Methods 66:177-180
40. Schewe C, Rizzello M, Dietel M, Hauptmann S (2000) PCR based diagnosis in pathology. Pathologe 21:218-228
41. Schewe C, Goldmann T, Grosser M, Zink A, Schluns K, Pahl S, Ulrichs T, Kaufmann SH, Nerlich A, Baretton GB, Dietel M, Vollmer E, Petersen I (2005) Inter-laboratory validation of PCR-based detection of Mycobacterium tuberculosis in formalin-fixed, paraffin-embedded tissues. Virchows Arch 447:573-585
42. Schiffman MH, Kiviat NB, Burk RD, Shah KV, Daniel RW, Lewis R, Kuypers J, Manos MM, Scott DR, Sherman ME, Kurman RJ, Stoler MH, Glass AG, Rush BB, Mielzynska I, Lorincz AT (1995) Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture. J Clin Microbiol 33:545-550
43. Snijders PJ, van den Brule AJ, Jacobs MV, Pol RP, Meijer CJ (2005) HPV DNA detection and typing in cervical scrapes. Methods Mol Med 119:101-114
44. Sotlar K, Diemer D, Dethleffs A, Hack Y, Stubner A, Vollmer N, Menton S, Menton M, Dietz K, Wallwiener D, Kandolf R, Bultmann B (2004) Detection and typing of human papillomavirus by e6 nested multiplex PCR. J Clin Microbiol 42:3176-3184
45. Sotlar K, Stubner A, Diemer D, Menton S, Menton M, Dietz K, Wallwiener D, Kandolf R, Bultmann B (2004) Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction. J Med Virol 74:107-116
46. Speich N, Schmitt C, Bollmann R, Bollmann M (2004) Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing: genotype spectrum of patients from the west German area. J Med Microbiol 53:125-128
47. Ting Y, Manos MM (1990) Detection and typing of genital human papillomaviruses. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds). PCR protocols, a guide to methods and applications. Academic, San Diego, New York, pp 356-367
48. von Knebel Doeberitz M (2002) New markers for cervical dysplasia to visualise the genomic chaos created byaberrant oncogenic papillomavirus infections. Eur J Cancer 38:2229-2242
49. Wiegand P, Domhover J, Brinkmann B (1996) DNA degradation in formalin fixed tissues. Pathologe 17:451-454
50. Will C, Schewe C, Schluns K, Petersen I (2006) HPV typing and CGH analysis for the differentiation of primary and metastatic squamous cell carcinomas of the aerodigestive tract. Cell Oncol 28:97-105
51. Yoshikawa H, Kawana T, Kitagawa K, Mizuno M, Yoshikura H, Iwamoto A (1991) Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn J Cancer Res 82:524-531
52. Zimmermann DR, Ruoslahti E (1989) Multiple domains of the large fibroblast proteoglycan, versican. EMBO J 8:2975-2981
53. zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2:342-350